Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases

Published:2023-12 Issue: Volume:11 Page:100521
ISSN:2352-0477
Container-title:European Journal of Radiology Open
language:en
Short-container-title:European Journal of Radiology Open

Author:

Lv Xinna,Li Ye,Xu Xiaoyue,Zheng Ziwei,Li Fang,Fang Kun,Wang Yue,Wang Bing,Hou Dailun

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives;Imyanitov;Crit. Rev. Oncol. Hematol.,2021

2. Molecular characterization and therapeutic approaches to small cell lung cancer: imaging implications;Park;Radiology,2022

3. Treatment of brain metastases;Matzenauer;Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub.,2016

4. Osimertinib plus Selumetinib in EGFR-mutated non-small cell lung cancer after progression on EGFR-TKIs: a Phase Ib, open-label, multicenter trial (TATTON Part B);Yang;Clin. Cancer Res. CCR,2022

5. Osimertinib: a review in previously untreated, EGFR mutation-positive, advanced NSCLC;Lamb;Target Oncol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP